Digitoxin
- Generic Name
- Digitoxin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C41H64O13
- CAS Number
- 71-63-6
- Unique Ingredient Identifier
- E90NZP2L9U
- Background
A cardiac glycoside sometimes used in place of digoxin. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)
- Indication
For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.
- Associated Conditions
- Atrial Fibrillation, Atrial Fibrillation or Flutter, Atrial Flutter, Chronic Heart Failure (CHF), Tachyarrhythmias
- Associated Therapies
- -
Phase II Study of Digitoxin to Treat Cystic Fibrosis
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 24
- Registration Number
- NCT00782288
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath